Remote Assessment of Ataxia Severity in SCA3 Across Multiple Centers and Time Points
ABSTRACT Objective Spinocerebellar ataxia type 3 (SCA3) is a genetically defined ataxia. The Scale for Assessment and Rating of Ataxia (SARA) is a clinician‐reported outcome that measures ataxia severity at a single time point. In its standard application, SARA fails to capture short‐term fluctuations, limiting its sensitivity in trials.
Marcus Grobe‐Einsler +20 more
wiley +1 more source
A plain language summary of patient preferences for treatments for multiple myeloma that has relapsed or is refractory to prior therapy. [PDF]
Ailawadhi S +10 more
europepmc +1 more source
Correction: Are plain language summaries published in health journals written according to instructions and health literacy principles? A systematic environmental scan [PDF]
openalex +1 more source
ABSTRACT Introduction Progressive Supranuclear Palsy (PSP) is a neurodegenerative ‘tauopathy’ with predominating pathology in the basal ganglia and midbrain. Caudal tau spread frequently implicates the cerebellum; however, the pattern of atrophy remains equivocal.
Chloe Spiegel +8 more
wiley +1 more source
Diagnostic pathways, cardiac manifestations, and outcomes in light chain amyloidosis: a plain language summary. [PDF]
Lyons G +5 more
europepmc +1 more source
Evaluating nêhiyawêtân: A computer assisted language learning (CALL) application for Plains Cree
Megan Bontogon
openalex +1 more source
A 73‐Year‐Old Man With Several Years of Difficulty Climbing Stairs and Frequent Tripping
ABSTRACT A 73‐year‐old man presented with progressive weakness and atrophy predominantly affecting the distal finger flexors and quadriceps muscles. Electrophysiological studies demonstrated mixed myogenic and neurogenic features. Muscle MRI showed inflammatory changes, and muscle biopsy revealed granulomatous myositis with histologic features ...
Mehmet Can Sari +3 more
wiley +1 more source
Jabberwock Jargon and Plain Language
Kerry K. Carney
doaj +1 more source
Plain language summary about tirabrutinib in relapsed/refractory primary central nervous system lymphoma. [PDF]
Sugiyama K +11 more
europepmc +1 more source

